people get REGN breaking news and analysis by email alert.
Get email alerts on REGN
To screen ETFs by asset class, performance, yield and more, check out the
Regeneron Pharmaceuticals, Inc. (REGN)
Be faster and smarter about REGN. Get PRO Alerts on all your stocks for just $30.
Want to be faster and smarter about REGN? Upgrade to PRO Alerts.
vs. ETF Alternatives
Regeneron Pharmaceuticals Inc is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog
at Zacks.com (Jan 14, 2015)
Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - Analyst Blog
at Zacks.com (Jan 13, 2015)
Regeneron/Sanofi Seek PCSK9 Drug Praluent Approval in EU - Analyst Blog
at Zacks.com (Jan 12, 2015)
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2
at Benzinga.com (Jan 12, 2015)
Nasdaq 100 Movers: SNDK, CELG
at Nasdaq.com (Jan 12, 2015)
See More »
Other News & PR
See More »
Xignite quote data
© 2015 Seeking Alpha